Perhaps these increased rates of RF and anti-CCP in LGL leukemia can be explained by the presence of increased JAK/STAT signaling or activating STAT3 mutations as observed in our cohort. The gene discussed is STAT3; the disease is T-cell large granular lymphocyte leukemia.